InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
62,275.40
(
2.27%
)
Post# of 252434
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: genisi post# 134299

Wednesday, 01/04/2012 7:14:44 AM

Wednesday, January 04, 2012 7:14:44 AM

Post# of 252434

Makes sense as it seems more logical to use an mTor inhibitor after Sutent instead of another (although different) TKI.

Have there been trials, or do you know if there are any ongoing trials or plans for trials, to combine an mTor inhibitor with Sutent or other TKIs instead of using one after the other in these types of patient populations?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up